14
Participants
Start Date
October 22, 2023
Primary Completion Date
October 20, 2026
Study Completion Date
October 20, 2027
BGT007 Injection
BGT007 injection (d0) were infused intravenously once, and the dose group was 5.0× 10\^7 cells,1.0 ×10\^8 cells, 3.0× 10\^8 cells,1.0 × 10\^9 cells,3.0 ×10\^9 cells.
RECRUITING
he Affiliated Hospital of Xuzhou Medical University, Xuzhou
Guangzhou Bioresette Biomedical Technology Co., Ltd.
INDUSTRY
The Affiliated Hospital of Xuzhou Medical University
OTHER